Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial - Chupp, G L; Bradford, E S; Albers, F C (Lancet Respir Med, 2017)
et al.